SCHEMBL7679062

SCHEMBL7679062

Cc1cccn2cc(-c3ccc(OC(C)N(C(C)C)C(C)C)cc3)nc12

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.60
NPC1 O15118 6/20 0.60
RAB9A P51151 6/20 0.60
NFKB1 P19838 3/20 0.60
NFKB2 Q00653 3/20 0.60
RELA Q04206 3/20 0.60
GAA P10253 2/20 0.60
KDM4E B2RXH2 5/20 0.58
HSD17B10 Q99714 3/20 0.58
SMN1; SMN2 Q16637 3/20 0.58
TP53 P04637 2/20 0.58
NPSR1 Q6W5P4 2/20 0.58
HPGD P15428 2/20 0.58
TSHR P16473 1/20 0.58
HRH3 Q9Y5N1 10/20 0.57
PKM P14618 1/20 0.57
LMNA P02545 1/20 0.53
POLB P06746 1/20 0.52
L3MBTL1 Q9Y468 1/20 0.49
MAPT P10636 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7680792 0.86 HRH3 (0.58) ALDH1A1NPC1RAB9ANFKB1NFKB2
SCHEMBL7675253 0.84 NPC1 (0.65) ALDH1A1NPC1RAB9ANFKB1NFKB2
SCHEMBL13325759 0.79 NPC1 (0.73) ALDH1A1NPC1RAB9ANFKB1NFKB2
SCHEMBL7681716 0.79 HRH3 (0.61) ALDH1A1NPC1RAB9ANFKB1NFKB2
SCHEMBL5411351 0.79 NPC1 (0.61) ALDH1A1NPC1RAB9ANFKB1NFKB2
SCHEMBL7679066 0.78 HRH3 (0.72) ALDH1A1NPC1RAB9ANFKB1NFKB2
SCHEMBL7680802 0.77 HRH3 (0.63) ALDH1A1NPC1RAB9ANFKB1NFKB2
SCHEMBL2617338 0.76 ALDH1A1 (1.00) ALDH1A1NPC1RAB9ANFKB1NFKB2
SCHEMBL5261748 0.76 HRH3 (0.61) ALDH1A1NPC1RAB9ANFKB1NFKB2
SCHEMBL7684201 0.75 HRH3 (0.67) ALDH1A1NPC1RAB9ANFKB1NFKB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6489337-B1 TREATMENT OF ALZHEIMER'S DISEASE, EPILEPSY, EATING DISORDERS, LEARNING AND MEMORY DISORDERS, MIGRAINE, SLEEP/WAKE DISORDERS, ALLERGIC RHINITIS, SCHIZOPHRENIA, MILD COGNITIVE IMPAIRMENT, AND ASTHMA ORTHO-MCNEIL PHARMACEUTICAL, INC. 2002-12-03 US claimed
WO-2001074813-A2 METHOD FOR USING 2- OR 3-ARYL SUBSTITUTED IMIDAZO[1,2-a] PYRIDINES AS H3 ANTAGONISTS ORTHO MCNEIL PHARMACEUTICAL, INC. (US) 2001-10-11 WO claimed
US-6489337-B1 TREATMENT OF ALZHEIMER'S DISEASE, EPILEPSY, EATING DISORDERS, LEARNING AND MEMORY DISORDERS, MIGRAINE, SLEEP/WAKE DISORDERS, ALLERGIC RHINITIS, SCHIZOPHRENIA, MILD COGNITIVE IMPAIRMENT, AND ASTHMA ORTHO-MCNEIL PHARMACEUTICAL, INC. 2002-12-03 US disclosed
WO-2001074813-A2 METHOD FOR USING 2- OR 3-ARYL SUBSTITUTED IMIDAZO[1,2-a] PYRIDINES AS H3 ANTAGONISTS ORTHO MCNEIL PHARMACEUTICAL, INC. (US) 2001-10-11 WO disclosed